KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Quest Diagnostics (DGX) Long-Term Debt Repayments: 2009-2025

Historic Long-Term Debt Repayments for Quest Diagnostics (DGX) over the last 15 years, with Sep 2025 value amounting to $10.0 million.

  • Quest Diagnostics' Long-Term Debt Repayments rose 900.00% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 23.22%. This contributed to the annual value of $303.0 million for FY2024, which is 83.57% down from last year.
  • Latest data reveals that Quest Diagnostics reported Long-Term Debt Repayments of $10.0 million as of Q3 2025, which was down 97.51% from $401.0 million recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Long-Term Debt Repayments peaked at $688.0 million during Q2 2023, and registered a low of $1.0 million during Q1 2021.
  • In the last 3 years, Quest Diagnostics' Long-Term Debt Repayments had a median value of $351.0 million in 2024 and averaged $315.8 million.
  • Its Long-Term Debt Repayments has fluctuated over the past 5 years, first plummeted by 99.88% in 2021, then spiked by 41,700.00% in 2023.
  • Quarterly analysis of 5 years shows Quest Diagnostics' Long-Term Debt Repayments stood at $1.0 million in 2021, then remained steady at $1.0 million in 2022, then surged by 41,700.00% to $418.0 million in 2023, then crashed by 99.76% to $1.0 million in 2024, then spiked by 900.00% to $10.0 million in 2025.
  • Its last three reported values are $10.0 million in Q3 2025, $401.0 million for Q2 2025, and $600.0 million during Q1 2025.